MV TELEGRAPH DAILY NEWS
Former Congressman Dave Weldon addresses a small crowd in The Villages, Fla. Brendan Farrington | AP The White House has pulled President Donald Trump’s nominee to lead the Centers for Disease Control and Prevention, former Rep. Dave Weldon, the Senate’s health committee confirmed Thursday. The move came just hours before the former Florida lawmaker, a …
Continue reading “White Home pulls Trump CDC Director nominee Dave Weldon”
Hinge Health’s TrueMotion feature. Courtesy: Hinge Health Digital physical therapy startup Hinge Health is gearing up to file for an initial public offering, potentially as soon as next week, CNBC has learned. Hinge Health helps patients with musculoskeletal injuries ranging from minor sprains to chronic pain recover from the comfort of their own homes. Its IPO …
Continue reading “Hinge Well being to go public as quickly as April, supply says”
Microsoft is giving its health-care artificial intelligence tools a makeover. The company on Monday unveiled a new voice-activated AI assistant that combines capabilities from its dictation solution, Dragon Medical One, and ambient listening solution, DAX Copilot, into one tool. “Dragon Copilot” will be able to help doctors quickly pull information from medical sources and automatically …
Continue reading “Microsoft unveils Dragon Copilot, a voice-activated AI device for medical doctors”
FILE PHOTO: The headquarters of the U.S. Food and Drug Administration (FDA) is seen in Silver Spring, Maryland November 4, 2009. Jason Reed | Reuters A crucial March meeting of vaccine advisors to the Food and Drug Administration has been canceled without explanation, a member of the advisory panel told CNBC on Wednesday. The meeting …
Continue reading “FDA cancels vaccine advisory assembly for selecting flu pictures”
Shares of Hims & Hers Health closed down around 26% on Friday after the U.S. Food and Drug Administration announced that the shortage of semaglutide injection products has been resolved. Semaglutide is the active ingredient in Novo Nordisk’s blockbuster weight loss drug Wegovy and diabetes treatment Ozempic. Those medications are part of a class of drugs called …
Continue reading “Hims & Hers shares fall after FDA says semaglutide not in scarcity”
Innovaccer CEO Abhinav Shashank. Courtesy: Innovaccer As doctors and nurses face historic rates of burnout, Innovacer says artificial intelligence is here to help. The health-care data company on Monday announced a suite of AI agents that are designed to automate repetitive, “low-value” tasks for clinicians. “We just don’t have enough capacity in the health system to …
Continue reading “Innovaccer launches AI brokers for docs, hospitals to repair burnout”
Paradromics’ Connexus Brain-Computer Interface. Courtesy: Paradromics Texas-based neurotech startup Paradromics on Wednesday announced a strategic partnership with Saudi Arabia’s Neom and said it will establish a Brain-Computer Interface Center of Excellence in the region. Neom is a developing area within northwest Saudi Arabia that’s touted as “a hub for innovation,” according to its website. The …
Continue reading “Neuralink competitor Paradromics companions with Saudi Arabia’s Neom”
Hims & Hers is facing scrutiny from lawmakers over an advertisement for its weight loss offerings that’s slated to run during the Super Bowl on Sunday. Sens. Dick Durbin, D-Ill., and Roger Marshall, R-Kan., wrote a letter to the U.S. Food and Drug Administration on Friday expressing concerns over an “upcoming advertisement” that “risks misleading …
Continue reading “Hims & Hers faces lawmaker scrutiny over ‘deceptive’ Tremendous Bowl advert”
Reid Hoffman, Partner at Greylock and co-founder LinkedIn, speaks during the WSJ Tech Live conference hosted by the Wall Street Journal at the Montage Laguna Beach in Laguna Beach, California, on October 21, 2024. Frederic J. Brown | Afp | Getty Images LinkedIn co-founder and venture capitalist Reid Hoffman became a billionaire from his business …
Continue reading “Reid Hoffman launches Manas AI, a brand new drug discovery startup”
Robert F. Kennedy Jr., President Donald Trump’s controversial pick to lead the Department of Health and Human Services, testified Wednesday before a crucial Senate panel, where he faced questions about past vaccine skepticism, his evolving views on abortion and grasp on sprawling federal health programs. Kennedy, 71, appeared first before the Senate Committee on Finance, …
Continue reading “RFK Jr. Senate affirmation listening to highlights”
